Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)-Reference-Cited by-同舟云学术

Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)

Published:2007 Issue:10 Volume:109 Page:2068-2076
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ottmann Oliver G.,Wassmann Barbara,Pfeifer Heike,Giagounidis Aristoteles,Stelljes Matthias,Dührsen Ulrich,Schmalzing Marc,Wunderle Lydia,Binckebanck Anja,Hoelzer Dieter,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. Acute lymphoblastic leukemia in the elderly

2. Acute lymphocytic leukemia (all) in elderly patients

3. Philadelphia-chromosome-positive adult acute lymphocytic leukemia: Characteristics, treatment results, and prognosis in 41 patients

4. Acute lymphoblastic leukemia in patients aged 60 years and over: a population-based study of incidence and outcome

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia;JAMA;2024-06-04

2. Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL;Journal of Clinical Oncology;2023-12-21

3. Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons;Hematology Reports;2023-11-26

4. Dasatinib plus prednisone as induction and consolidation for adults with Ph‐positive acute lymphoblastic leukaemia: A single‐arm, multicentre, phase 2 trial;British Journal of Haematology;2023-07-11

5. Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison;Advances in Therapy;2023-05-19